10X GENOMICS Financials
| 1KJ Stock | EUR 14.19 0.04 0.28% |
10X |
Understanding current and past 10X GENOMICS Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of 10X GENOMICS's financial statements are interrelated, with each one affecting the others. For example, an increase in 10X GENOMICS's assets may result in an increase in income on the income statement.
10X GENOMICS Stock Summary
10X GENOMICS competes with VIRGIN WINES, Ryanair Holdings, EAT WELL, DIVERSIFIED ROYALTY, and PennantPark Investment. 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California. 10X GENOMICS operates under Health Information Services classification in Germany and is traded on Frankfurt Stock Exchange. It employs 852 people.| Instrument | Germany Stock View All |
| Exchange | Frankfurt Exchange |
| ISIN | US88025U1097 |
| Business Address | 6230 Stoneridge Mall |
| Sector | Healthcare |
| Industry | Health Information Services |
| Benchmark | Dow Jones Industrial |
| Website | www.10xgenomics.com |
| Phone | 925 401 7300 |
| Currency | EUR - Euro |
You should never invest in 10X GENOMICS without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of 10X Stock, because this is throwing your money away. Analyzing the key information contained in 10X GENOMICS's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
10X GENOMICS Key Financial Ratios
There are many critical financial ratios that 10X GENOMICS's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that 10X GENOMICS DL reports annually and quarterly.| Return On Equity | -0.21 | |||
| Return On Asset | -0.0892 | |||
| Target Price | 197.56 | |||
| Beta | 1.67 | |||
| Z Score | 43.8 |
10X Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining 10X GENOMICS's current stock value. Our valuation model uses many indicators to compare 10X GENOMICS value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across 10X GENOMICS competition to find correlations between indicators driving 10X GENOMICS's intrinsic value. More Info.10X GENOMICS DL is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the 10X GENOMICS's earnings, one of the primary drivers of an investment's value.10X GENOMICS DL Systematic Risk
10X GENOMICS's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. 10X GENOMICS volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was ten with a total number of output elements of fifty-one. The Beta measures systematic risk based on how returns on 10X GENOMICS DL correlated with the market. If Beta is less than 0 10X GENOMICS generally moves in the opposite direction as compared to the market. If 10X GENOMICS Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one 10X GENOMICS DL is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of 10X GENOMICS is generally in the same direction as the market. If Beta > 1 10X GENOMICS moves generally in the same direction as, but more than the movement of the benchmark.
10X GENOMICS November 30, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of 10X GENOMICS help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of 10X GENOMICS DL. We use our internally-developed statistical techniques to arrive at the intrinsic value of 10X GENOMICS DL based on widely used predictive technical indicators. In general, we focus on analyzing 10X Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build 10X GENOMICS's daily price indicators and compare them against related drivers.
| Information Ratio | (0.10) | |||
| Maximum Drawdown | 31.23 | |||
| Value At Risk | (7.78) | |||
| Potential Upside | 8.01 |
Complementary Tools for 10X Stock analysis
When running 10X GENOMICS's price analysis, check to measure 10X GENOMICS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 10X GENOMICS is operating at the current time. Most of 10X GENOMICS's value examination focuses on studying past and present price action to predict the probability of 10X GENOMICS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 10X GENOMICS's price. Additionally, you may evaluate how the addition of 10X GENOMICS to your portfolios can decrease your overall portfolio volatility.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |